Serveur d'exploration MERS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Proteolytic activation of the SARS-coronavirus spike protein: Cutting enzymes at the cutting edge of antiviral research

Identifieur interne : 002175 ( Main/Exploration ); précédent : 002174; suivant : 002176

Proteolytic activation of the SARS-coronavirus spike protein: Cutting enzymes at the cutting edge of antiviral research

Auteurs : Graham Simmons [États-Unis] ; Pawel Zmora [Allemagne] ; Stefanie Gierer [Allemagne] ; Adeline Heurich [Allemagne] ; Stefan Pöhlmann [Allemagne]

Source :

RBID : Pascal:14-0035479

Descripteurs français

English descriptors

Abstract

The severe acute respiratory syndrome (SARS) pandemic revealed that zoonotic transmission of animal coronaviruses (CoV) to humans poses a significant threat to public health and warrants surveillance and the development of countermeasures. The activity of host cell proteases, which cleave and activate the SARS-CoV spike (S) protein, is essential for viral infectivity and constitutes a target for intervention. However, the identities of the proteases involved have been unclear. Pioneer studies identified cathepsins and type II transmembrane serine proteases as cellular activators of SARS-CoV and demonstrated that several emerging viruses might exploit these enzymes to promote their spread. Here, we will review the proteolytic systems hijacked by SARS-CoV for S protein activation, we will discuss their contribution to viral spread in the host and we will outline antiviral strategies targeting these enzymes. This paper forms part of a series of invited articles in Antiviral Research on "From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses."

Url:


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Proteolytic activation of the SARS-coronavirus spike protein: Cutting enzymes at the cutting edge of antiviral research</title>
<author>
<name sortKey="Simmons, Graham" sort="Simmons, Graham" uniqKey="Simmons G" first="Graham" last="Simmons">Graham Simmons</name>
<affiliation wicri:level="2">
<inist:fA14 i1="01">
<s1>Blood Systems Research Institute, 270 Masonic Ave</s1>
<s2>San Francisco, CA 94118</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Zmora, Pawel" sort="Zmora, Pawel" uniqKey="Zmora P" first="Pawel" last="Zmora">Pawel Zmora</name>
<affiliation wicri:level="3">
<inist:fA14 i1="02">
<s1>Infection Biology Unit, German Primate Center, Kellnerweg 4</s1>
<s2>37077 Göttingen</s2>
<s3>DEU</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<placeName>
<region type="land" nuts="2">Basse-Saxe</region>
<settlement type="city">Göttingen</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Gierer, Stefanie" sort="Gierer, Stefanie" uniqKey="Gierer S" first="Stefanie" last="Gierer">Stefanie Gierer</name>
<affiliation wicri:level="3">
<inist:fA14 i1="02">
<s1>Infection Biology Unit, German Primate Center, Kellnerweg 4</s1>
<s2>37077 Göttingen</s2>
<s3>DEU</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<placeName>
<region type="land" nuts="2">Basse-Saxe</region>
<settlement type="city">Göttingen</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Heurich, Adeline" sort="Heurich, Adeline" uniqKey="Heurich A" first="Adeline" last="Heurich">Adeline Heurich</name>
<affiliation wicri:level="3">
<inist:fA14 i1="02">
<s1>Infection Biology Unit, German Primate Center, Kellnerweg 4</s1>
<s2>37077 Göttingen</s2>
<s3>DEU</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<placeName>
<region type="land" nuts="2">Basse-Saxe</region>
<settlement type="city">Göttingen</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Pohlmann, Stefan" sort="Pohlmann, Stefan" uniqKey="Pohlmann S" first="Stefan" last="Pöhlmann">Stefan Pöhlmann</name>
<affiliation wicri:level="3">
<inist:fA14 i1="02">
<s1>Infection Biology Unit, German Primate Center, Kellnerweg 4</s1>
<s2>37077 Göttingen</s2>
<s3>DEU</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<placeName>
<region type="land" nuts="2">Basse-Saxe</region>
<settlement type="city">Göttingen</settlement>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">14-0035479</idno>
<date when="2013">2013</date>
<idno type="stanalyst">PASCAL 14-0035479 INIST</idno>
<idno type="RBID">Pascal:14-0035479</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000031</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000063</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000038</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000038</idno>
<idno type="wicri:doubleKey">0166-3542:2013:Simmons G:proteolytic:activation:of</idno>
<idno type="wicri:Area/Main/Merge">002199</idno>
<idno type="wicri:source">PMC</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3889862</idno>
<idno type="RBID">PMC:3889862</idno>
<idno type="wicri:Area/Pmc/Corpus">001274</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">001274</idno>
<idno type="wicri:Area/Pmc/Curation">001274</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">001274</idno>
<idno type="wicri:Area/Pmc/Checkpoint">001186</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">001186</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:24121034</idno>
<idno type="wicri:Area/PubMed/Corpus">001B61</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001B61</idno>
<idno type="wicri:Area/PubMed/Curation">001B61</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001B61</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001A83</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001A83</idno>
<idno type="wicri:Area/Ncbi/Merge">000B78</idno>
<idno type="wicri:Area/Ncbi/Curation">000B78</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000B78</idno>
<idno type="wicri:doubleKey">0166-3542:2013:Simmons G:proteolytic:activation:of</idno>
<idno type="wicri:Area/Main/Merge">001F42</idno>
<idno type="wicri:Area/Main/Curation">002175</idno>
<idno type="wicri:Area/Main/Exploration">002175</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Proteolytic activation of the SARS-coronavirus spike protein: Cutting enzymes at the cutting edge of antiviral research</title>
<author>
<name sortKey="Simmons, Graham" sort="Simmons, Graham" uniqKey="Simmons G" first="Graham" last="Simmons">Graham Simmons</name>
<affiliation wicri:level="2">
<inist:fA14 i1="01">
<s1>Blood Systems Research Institute, 270 Masonic Ave</s1>
<s2>San Francisco, CA 94118</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Zmora, Pawel" sort="Zmora, Pawel" uniqKey="Zmora P" first="Pawel" last="Zmora">Pawel Zmora</name>
<affiliation wicri:level="3">
<inist:fA14 i1="02">
<s1>Infection Biology Unit, German Primate Center, Kellnerweg 4</s1>
<s2>37077 Göttingen</s2>
<s3>DEU</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<placeName>
<region type="land" nuts="2">Basse-Saxe</region>
<settlement type="city">Göttingen</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Gierer, Stefanie" sort="Gierer, Stefanie" uniqKey="Gierer S" first="Stefanie" last="Gierer">Stefanie Gierer</name>
<affiliation wicri:level="3">
<inist:fA14 i1="02">
<s1>Infection Biology Unit, German Primate Center, Kellnerweg 4</s1>
<s2>37077 Göttingen</s2>
<s3>DEU</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<placeName>
<region type="land" nuts="2">Basse-Saxe</region>
<settlement type="city">Göttingen</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Heurich, Adeline" sort="Heurich, Adeline" uniqKey="Heurich A" first="Adeline" last="Heurich">Adeline Heurich</name>
<affiliation wicri:level="3">
<inist:fA14 i1="02">
<s1>Infection Biology Unit, German Primate Center, Kellnerweg 4</s1>
<s2>37077 Göttingen</s2>
<s3>DEU</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<placeName>
<region type="land" nuts="2">Basse-Saxe</region>
<settlement type="city">Göttingen</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Pohlmann, Stefan" sort="Pohlmann, Stefan" uniqKey="Pohlmann S" first="Stefan" last="Pöhlmann">Stefan Pöhlmann</name>
<affiliation wicri:level="3">
<inist:fA14 i1="02">
<s1>Infection Biology Unit, German Primate Center, Kellnerweg 4</s1>
<s2>37077 Göttingen</s2>
<s3>DEU</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<placeName>
<region type="land" nuts="2">Basse-Saxe</region>
<settlement type="city">Göttingen</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Antiviral research</title>
<title level="j" type="abbreviated">Antivir. res.</title>
<idno type="ISSN">0166-3542</idno>
<imprint>
<date when="2013">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Antiviral research</title>
<title level="j" type="abbreviated">Antivir. res.</title>
<idno type="ISSN">0166-3542</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Activation</term>
<term>Antiviral</term>
<term>Cathepsin L</term>
<term>Cathepsins (metabolism)</term>
<term>Communicable Diseases, Emerging</term>
<term>Coronavirus Infections (virology)</term>
<term>Endosomes (metabolism)</term>
<term>Enzyme</term>
<term>Humans</term>
<term>Lung (enzymology)</term>
<term>Lung (pathology)</term>
<term>Lung (virology)</term>
<term>Membrane Proteins (metabolism)</term>
<term>Middle East respiratory syndrome</term>
<term>Models, Biological</term>
<term>Peptidyl-Dipeptidase A (metabolism)</term>
<term>Protein</term>
<term>Protein S</term>
<term>Proteolysis</term>
<term>SARS Virus (physiology)</term>
<term>Serine Endopeptidases (metabolism)</term>
<term>Serine Proteases (metabolism)</term>
<term>Severe Acute Respiratory Syndrome (pathology)</term>
<term>Severe Acute Respiratory Syndrome (virology)</term>
<term>Severe acute respiratory syndrome</term>
<term>Severe acute respiratory syndrome virus</term>
<term>Spike Glycoprotein, Coronavirus (metabolism)</term>
<term>Structure activity relation</term>
<term>Virus Internalization</term>
<term>Virus Replication</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Cathepsines (métabolisme)</term>
<term>Endosomes (métabolisme)</term>
<term>Glycoprotéine de spicule des coronavirus (métabolisme)</term>
<term>Humains</term>
<term>Infections à coronavirus (virologie)</term>
<term>Maladies transmissibles émergentes</term>
<term>Modèles biologiques</term>
<term>Peptidyl-Dipeptidase A (métabolisme)</term>
<term>Poumon (anatomopathologie)</term>
<term>Poumon (enzymologie)</term>
<term>Poumon (virologie)</term>
<term>Protéases à sérine (métabolisme)</term>
<term>Protéines membranaires (métabolisme)</term>
<term>Protéolyse</term>
<term>Pénétration virale</term>
<term>Réplication virale</term>
<term>Serine endopeptidases (métabolisme)</term>
<term>Syndrome respiratoire aigu sévère (anatomopathologie)</term>
<term>Syndrome respiratoire aigu sévère (virologie)</term>
<term>Virus du SRAS (physiologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Cathepsins</term>
<term>Membrane Proteins</term>
<term>Peptidyl-Dipeptidase A</term>
<term>Serine Endopeptidases</term>
<term>Serine Proteases</term>
<term>Spike Glycoprotein, Coronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr">
<term>Poumon</term>
<term>Syndrome respiratoire aigu sévère</term>
</keywords>
<keywords scheme="MESH" qualifier="enzymologie" xml:lang="fr">
<term>Poumon</term>
</keywords>
<keywords scheme="MESH" qualifier="enzymology" xml:lang="en">
<term>Lung</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Endosomes</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Cathepsines</term>
<term>Endosomes</term>
<term>Glycoprotéine de spicule des coronavirus</term>
<term>Peptidyl-Dipeptidase A</term>
<term>Protéases à sérine</term>
<term>Protéines membranaires</term>
<term>Serine endopeptidases</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Lung</term>
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr">
<term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en">
<term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr">
<term>Infections à coronavirus</term>
<term>Poumon</term>
<term>Syndrome respiratoire aigu sévère</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en">
<term>Coronavirus Infections</term>
<term>Lung</term>
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Communicable Diseases, Emerging</term>
<term>Humans</term>
<term>Models, Biological</term>
<term>Proteolysis</term>
<term>Virus Internalization</term>
<term>Virus Replication</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Activation</term>
<term>Humains</term>
<term>Maladies transmissibles émergentes</term>
<term>Modèles biologiques</term>
<term>Protéolyse</term>
<term>Pénétration virale</term>
<term>Réplication virale</term>
<term>Virus syndrome respiratoire aigu sévère</term>
<term>Protéine</term>
<term>Enzyme</term>
<term>Antiviral</term>
<term>Relation structure activité</term>
<term>Syndrome respiratoire aigu sévère</term>
<term>Cathepsin L</term>
<term>Protéine S</term>
<term>Protéolyse</term>
<term>Transmembrane protease serine 2</term>
<term>Syndrome respiratoire du Moyen-Orient</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Enzyme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The severe acute respiratory syndrome (SARS) pandemic revealed that zoonotic transmission of animal coronaviruses (CoV) to humans poses a significant threat to public health and warrants surveillance and the development of countermeasures. The activity of host cell proteases, which cleave and activate the SARS-CoV spike (S) protein, is essential for viral infectivity and constitutes a target for intervention. However, the identities of the proteases involved have been unclear. Pioneer studies identified cathepsins and type II transmembrane serine proteases as cellular activators of SARS-CoV and demonstrated that several emerging viruses might exploit these enzymes to promote their spread. Here, we will review the proteolytic systems hijacked by SARS-CoV for S protein activation, we will discuss their contribution to viral spread in the host and we will outline antiviral strategies targeting these enzymes. This paper forms part of a series of invited articles in Antiviral Research on "From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses."</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Allemagne</li>
<li>États-Unis</li>
</country>
<region>
<li>Basse-Saxe</li>
<li>Californie</li>
</region>
<settlement>
<li>Göttingen</li>
</settlement>
</list>
<tree>
<country name="États-Unis">
<region name="Californie">
<name sortKey="Simmons, Graham" sort="Simmons, Graham" uniqKey="Simmons G" first="Graham" last="Simmons">Graham Simmons</name>
</region>
</country>
<country name="Allemagne">
<region name="Basse-Saxe">
<name sortKey="Zmora, Pawel" sort="Zmora, Pawel" uniqKey="Zmora P" first="Pawel" last="Zmora">Pawel Zmora</name>
</region>
<name sortKey="Gierer, Stefanie" sort="Gierer, Stefanie" uniqKey="Gierer S" first="Stefanie" last="Gierer">Stefanie Gierer</name>
<name sortKey="Heurich, Adeline" sort="Heurich, Adeline" uniqKey="Heurich A" first="Adeline" last="Heurich">Adeline Heurich</name>
<name sortKey="Pohlmann, Stefan" sort="Pohlmann, Stefan" uniqKey="Pohlmann S" first="Stefan" last="Pöhlmann">Stefan Pöhlmann</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002175 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002175 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     Pascal:14-0035479
   |texte=   Proteolytic activation of the SARS-coronavirus spike protein: Cutting enzymes at the cutting edge of antiviral research
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021